0 XP   0   0   0

Small Pharma Inc
Buy, Hold or Sell?

Should you buy, hold or sell Small Pharma Inc?

I guess you are interested in Small Pharma Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Small Pharma Inc

Let's start. I'm going to help you getting a better view of Small Pharma Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Small Pharma Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Small Pharma Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Small Pharma Inc. The closing price on 2023-01-31 was C$0.125 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Small Pharma Inc Daily Candlestick Chart
Small Pharma Inc Daily Candlestick Chart
Summary









1. Valuation of Small Pharma Inc




Current price per share

C$0.13

2. Growth of Small Pharma Inc




Is Small Pharma Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$18.6m$39.5m-$12.4m-46.2%

How much money is Small Pharma Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.2m-$3.7m-$441.1k-10.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Small Pharma Inc




Comparing to competitors in the Biotechnology industry




  Industry Rankings (Biotechnology)  


Richest
#803 / 1232

Most Revenue
#1194 / 1232

Most Profit
#473 / 1232

Most Efficient
#596 / 1232


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Small Pharma Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Small Pharma Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Small Pharma Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Small Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--223.6%+223.6%
TTM--281.7%+281.7%
YOY--344.8%+344.8%
5Y--450.1%+450.1%
10Y--541.0%+541.0%
1.1.2. Return on Assets

Shows how efficient Small Pharma Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Small Pharma Inc to the Biotechnology industry mean.
  • -25.3% Return on Assets means that Small Pharma Inc generated $-0.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Small Pharma Inc:

  • The MRQ is -25.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.3%TTM-15.3%-10.0%
TTM-15.3%YOY-9.3%-6.0%
TTM-15.3%5Y-13.3%-2.0%
5Y-13.3%10Y-13.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.3%-9.9%-15.4%
TTM-15.3%-8.9%-6.4%
YOY-9.3%-9.3%+0.0%
5Y-13.3%-11.7%-1.6%
10Y-13.3%-12.7%-0.6%
1.1.3. Return on Equity

Shows how efficient Small Pharma Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Small Pharma Inc to the Biotechnology industry mean.
  • -29.8% Return on Equity means Small Pharma Inc generated $-0.30 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Small Pharma Inc:

  • The MRQ is -29.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -17.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.8%TTM-17.3%-12.6%
TTM-17.3%YOY-9.6%-7.7%
TTM-17.3%5Y-14.7%-2.6%
5Y-14.7%10Y-14.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.8%-12.0%-17.8%
TTM-17.3%-11.5%-5.8%
YOY-9.6%-10.8%+1.2%
5Y-14.7%-14.2%-0.5%
10Y-14.7%-15.2%+0.5%

1.2. Operating Efficiency of Small Pharma Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Small Pharma Inc is operating .

  • Measures how much profit Small Pharma Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Small Pharma Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Small Pharma Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.3%+207.3%
TTM--271.0%+271.0%
YOY--325.9%+325.9%
5Y--454.0%+454.0%
10Y--537.1%+537.1%
1.2.2. Operating Ratio

Measures how efficient Small Pharma Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Small Pharma Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.871-2.871
TTM-3.504-3.504
YOY-3.604-3.604
5Y-5.132-5.132
10Y-6.371-6.371

1.3. Liquidity of Small Pharma Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Small Pharma Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.62 means the company has $6.62 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Small Pharma Inc:

  • The MRQ is 6.621. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.370. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.621TTM10.370-3.749
TTM10.370YOY32.592-22.221
TTM10.3705Y17.777-7.407
5Y17.77710Y17.7770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.6215.117+1.504
TTM10.3705.755+4.615
YOY32.5925.854+26.738
5Y17.7776.511+11.266
10Y17.7776.222+11.555
1.3.2. Quick Ratio

Measures if Small Pharma Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Small Pharma Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.16 means the company can pay off $0.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Small Pharma Inc:

  • The MRQ is 0.155. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.185. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.155TTM0.185-0.030
TTM0.185YOY0.336-0.151
TTM0.1855Y0.235-0.050
5Y0.23510Y0.2350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1554.284-4.129
TTM0.1854.664-4.479
YOY0.3364.787-4.451
5Y0.2355.218-4.983
10Y0.2355.182-4.947

1.4. Solvency of Small Pharma Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Small Pharma Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Small Pharma Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Small Pharma Inc assets are financed with 15.1% credit (debt) and the remaining percentage (100% - 15.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Small Pharma Inc:

  • The MRQ is 0.151. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.101. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.151TTM0.101+0.050
TTM0.101YOY0.032+0.069
TTM0.1015Y0.078+0.023
5Y0.07810Y0.0780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1510.278-0.127
TTM0.1010.277-0.176
YOY0.0320.306-0.274
5Y0.0780.367-0.289
10Y0.0780.403-0.325
1.4.2. Debt to Equity Ratio

Measures if Small Pharma Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Small Pharma Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 17.8% means that company has $0.18 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Small Pharma Inc:

  • The MRQ is 0.178. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.114. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.178TTM0.114+0.064
TTM0.114YOY0.033+0.081
TTM0.1145Y0.087+0.027
5Y0.08710Y0.0870.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1780.315-0.137
TTM0.1140.317-0.203
YOY0.0330.319-0.286
5Y0.0870.403-0.316
10Y0.0870.462-0.375

2. Market Valuation of Small Pharma Inc

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Small Pharma Inc generates.

  • Above 15 is considered overpriced but always compare Small Pharma Inc to the Biotechnology industry mean.
  • A PE ratio of -13.63 means the investor is paying $-13.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Small Pharma Inc:

  • The EOD is -5.408. Company is losing money. -2
  • The MRQ is -13.629. Company is losing money. -2
  • The TTM is -17.561. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-5.408MRQ-13.629+8.221
MRQ-13.629TTM-17.561+3.932
TTM-17.561YOY-24.644+7.083
TTM-17.5615Y-19.922+2.361
5Y-19.92210Y-19.9220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.408-8.986+3.578
MRQ-13.629-9.792-3.837
TTM-17.561-16.243-1.318
YOY-24.644-20.876-3.768
5Y-19.922-16.665-3.257
10Y-19.922-14.732-5.190
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Small Pharma Inc.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of Small Pharma Inc:

  • The MRQ is -19.106. Very Bad. -2
  • The TTM is -19.826. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-19.106TTM-19.826+0.720
TTM-19.826YOY-21.237+1.411
TTM-19.8265Y-20.108+0.282
5Y-20.10810Y-20.1080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.106-0.032-19.074
TTM-19.8260.004-19.830
YOY-21.2370.016-21.253
5Y-20.1080.006-20.114
10Y-20.1080.003-20.111

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Small Pharma Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 4.07 means the investor is paying $4.07 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Small Pharma Inc:

  • The EOD is 1.614. Good. +1
  • The MRQ is 4.067. Neutral. Compare to industry.
  • The TTM is 2.684. Good. +1
Trends
Current periodCompared to+/- 
EOD1.614MRQ4.067-2.453
MRQ4.067TTM2.684+1.383
TTM2.684YOY2.766-0.082
TTM2.6845Y2.712-0.027
5Y2.71210Y2.7120.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.6141.835-0.221
MRQ4.0672.006+2.061
TTM2.6842.774-0.090
YOY2.7663.453-0.687
5Y2.7122.713-0.001
10Y2.7122.402+0.310
2. Total Gains per Share

2.4. Latest News of Small Pharma Inc

Does Small Pharma Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Small Pharma Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2023-01-09
13:50
First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026Read

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Small Pharma Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.026-0.020-21%0.079-132%0.013-298%0.013-298%
Book Value Growth--0.7530.838-10%0.933-19%0.857-12%0.857-12%
Book Value Per Share--0.0770.112-31%0.164-53%0.130-40%0.130-40%
Book Value Per Share Growth--0.7520.838-10%0.933-19%0.857-12%0.857-12%
Current Ratio--6.62110.370-36%32.592-80%17.777-63%17.777-63%
Debt To Asset Ratio--0.1510.101+49%0.032+372%0.078+93%0.078+93%
Debt To Equity Ratio--0.1780.114+56%0.033+437%0.087+104%0.087+104%
Dividend Per Share----0%-0%-0%-0%
Eps---0.023-0.018-24%-0.020-14%-0.018-20%-0.018-20%
Eps Growth--0.7130.863-17%1.455-51%0.981-27%0.981-27%
Free Cash Flow Per Share---0.019-0.016-12%-0.012-37%-0.015-21%-0.015-21%
Free Cash Flow Per Share Growth--1.0520.776+36%1.417-26%0.904+16%0.904+16%
Free Cash Flow To Equity Per Share---0.019-0.016-15%0.072-127%0.013-246%0.013-246%
Free Cash Flow To Equity Per Share Growth--1.0250.768+33%-0.057+106%0.603+70%0.603+70%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--1.840--------
Intrinsic Value_10Y_min--1.503--------
Intrinsic Value_1Y_max---0.029--------
Intrinsic Value_1Y_min---0.029--------
Intrinsic Value_3Y_max--0.075--------
Intrinsic Value_3Y_min--0.069--------
Intrinsic Value_5Y_max--0.376--------
Intrinsic Value_5Y_min--0.335--------
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio1.614-152%4.0672.684+52%2.766+47%2.712+50%2.712+50%
Pe Ratio-5.408+60%-13.629-17.561+29%-24.644+81%-19.922+46%-19.922+46%
Peg Ratio---19.106-19.826+4%-21.237+11%-20.108+5%-20.108+5%
Price Per Share0.125-152%0.3150.293+8%0.455-31%0.347-9%0.347-9%
Price To Total Gains Ratio-4.885+60%-12.311-15.812+28%-17.784+44%-16.470+34%-16.470+34%
Profit Growth--0.7100.862-18%1.193-40%0.928-23%0.928-23%
Quick Ratio--0.1550.185-16%0.336-54%0.235-34%0.235-34%
Return On Assets---0.253-0.153-40%-0.093-63%-0.133-48%-0.133-48%
Return On Equity---0.298-0.173-42%-0.096-68%-0.147-51%-0.147-51%
Total Gains Per Share---0.026-0.020-21%0.079-132%0.013-298%0.013-298%
Total Gains Per Share Growth--0.9590.720+33%-0.067+107%0.563+70%0.563+70%
Usd Book Value--18675191.87027060714.744-31%39555429.365-53%31225619.617-40%31225619.617-40%
Usd Book Value Change Per Share---0.019-0.015-21%0.059-132%0.010-298%0.010-298%
Usd Book Value Per Share--0.0580.084-31%0.123-53%0.097-40%0.097-40%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.017-0.013-24%-0.015-14%-0.014-20%-0.014-20%
Usd Free Cash Flow---4484017.331-3920172.979-13%-2833209.540-37%-3557851.832-21%-3557851.832-21%
Usd Free Cash Flow Per Share---0.014-0.012-12%-0.009-37%-0.011-21%-0.011-21%
Usd Free Cash Flow To Equity Per Share---0.014-0.012-15%0.054-127%0.010-246%0.010-246%
Usd Price Per Share0.093-152%0.2350.219+8%0.340-31%0.259-9%0.259-9%
Usd Profit---5572807.229-4233654.961-24%-3792493.329-32%-4086601.084-27%-4086601.084-27%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.019-0.015-21%0.059-132%0.010-298%0.010-298%
 EOD+3 -2MRQTTM+5 -29YOY+4 -305Y+5 -2910Y+5 -29

3.2. Fundamental Score

Let's check the fundamental score of Small Pharma Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.408
Price to Book Ratio (EOD)Between0-11.614
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.155
Current Ratio (MRQ)Greater than16.621
Debt to Asset Ratio (MRQ)Less than10.151
Debt to Equity Ratio (MRQ)Less than10.178
Return on Equity (MRQ)Greater than0.15-0.298
Return on Assets (MRQ)Greater than0.05-0.253
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Small Pharma Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.140
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2022-08-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets29,423
Total Liabilities4,436
Total Stockholder Equity24,987
 As reported
Total Liabilities 4,436
Total Stockholder Equity+ 24,987
Total Assets = 29,423

Assets

Total Assets29,423
Total Current Assets29,368
Long-term Assets29,368
Total Current Assets
Cash And Cash Equivalents 27,145
Net Receivables 689
Total Current Assets  (as reported)29,368
Total Current Assets  (calculated)27,834
+/- 1,534
Long-term Assets
Property Plant Equipment 54
Long-term Assets  (as reported)54
Long-term Assets  (calculated)54
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities4,436
Long-term Liabilities0
Total Stockholder Equity24,987
Total Current Liabilities
Accounts payable 3,596
Total Current Liabilities  (as reported)4,436
Total Current Liabilities  (calculated)3,596
+/- 840
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock69,950
Retained Earnings -45,029
Other Stockholders Equity 66
Total Stockholder Equity (as reported)24,987
Total Stockholder Equity (calculated)24,987
+/-0
Other
Capital Stock69,950
Common Stock Shares Outstanding 322,611
Net Invested Capital 24,987
Net Tangible Assets 24,987
Net Working Capital 24,933



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2022-08-312022-05-312022-02-282021-11-302021-08-312021-05-31
> Total Assets 
56,020
53,293
48,621
45,574
36,543
29,423
29,42336,54345,57448,62153,29356,020
   > Total Current Assets 
53,454
50,730
46,058
43,012
33,980
29,368
29,36833,98043,01246,05850,73053,454
       Cash And Cash Equivalents 
52,774
50,287
45,624
40,656
31,999
27,145
27,14531,99940,65645,62450,28752,774
       Net Receivables 
637
375
369
1,214
653
689
6896531,214369375637
   > Long-term Assets 
2,566
2,563
2,562
2,562
2,563
54
542,5632,5622,5622,5632,566
       Property Plant Equipment 
66
63
62
62
63
54
546362626366
       Other Assets 
2,500
2,500
2,500
2,500
2,500
0
02,5002,5002,5002,5002,500
> Total Liabilities 
1,271
2,194
3,023
4,497
3,379
4,436
4,4363,3794,4973,0232,1941,271
   > Total Current Liabilities 
1,271
2,194
3,023
4,497
3,379
4,436
4,4363,3794,4973,0232,1941,271
       Accounts payable 
1,271
2,194
3,023
4,497
3,379
3,596
3,5963,3794,4973,0232,1941,271
   > Long-term Liabilities 000000
> Total Stockholder Equity
54,749
51,099
45,598
41,077
33,164
24,987
24,98733,16441,07745,59851,09954,749
   Common Stock
69,807
69,849
69,849
69,970
70,006
69,950
69,95070,00669,97069,84969,84969,807
   Retained Earnings -45,029-37,491-31,709-26,919-22,286-17,755
   Capital Surplus 000000
   Treasury Stock000000
   Other Stockholders Equity 
2,697
3,536
2,668
2,815
649
66
666492,8152,6683,5362,697



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2022-02-28)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-17,952
Operating Income-17,952-17,952
 
Operating Expense (+$)
Research Development4,828
Selling General Administrative13,104
Selling And Marketing Expenses-
Operating Expense17,95217,932
 
Net Interest Income (+$)
Interest Income-
Interest Expense-434
Net Interest Income-434-434
 
Pretax Income (+$)
Operating Income-17,952
Net Interest Income-434
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-22,921-13,417
EBIT - interestExpense = -15,998
-22,921
-21,832
Interest Expense434
Earnings Before Interest and Taxes (ebit)-15,564-22,487
Earnings Before Interest and Taxes (ebitda)-22,467
 
After tax Income (+$)
Income Before Tax-22,921
Tax Provision--655
Net Income From Continuing Ops-22,266-22,266
Net Income-22,266
Net Income Applicable To Common Shares-22,266
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-4,535434
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
CHP.VN
1 minute ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CHP.VN.

CHP.VN Daily Candlestick Chart
AGM.VN
1 minute ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of AGM.VN.

AGM.VN Daily Candlestick Chart
PVI.VN
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of PVI.VN.

PVI.VN Daily Candlestick Chart
CTF.VN
2 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CTF.VN.

CTF.VN Daily Candlestick Chart
DHM.VN
3 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of DHM.VN.

DHM.VN Daily Candlestick Chart
TVD.VN
3 minutes ago

I found you a Bearish Engulfing Candle Pattern on the daily chart of TVD.VN.

TVD.VN Daily Candlestick Chart
TVC.VN
3 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of TVC.VN.

TVC.VN Daily Candlestick Chart
NHH.VN
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NHH.VN.

NHH.VN Daily Candlestick Chart
LSS.VN
4 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of LSS.VN.

LSS.VN Daily Candlestick Chart
HAH.VN
5 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HAH.VN.

HAH.VN Daily Candlestick Chart
U14.SG
11 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of U14.SG.

U14.SG Daily Candlestick Chart
NKI.BK
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NKI.BK.

NKI.BK Daily Candlestick Chart
NS8U.SG
17 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of NS8U.SG.

NS8U.SG Daily Candlestick Chart
G92.SG
18 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of G92.SG.

G92.SG Daily Candlestick Chart
F83.SG
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of F83.SG.

F83.SG Daily Candlestick Chart
AJBU.SG
21 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of AJBU.SG.

AJBU.SG Daily Candlestick Chart
A17U.SG
22 minutes ago

I found you a Golden Cross on the daily chart of A17U.SG.

A17U.SG Daily Candlestick Chart
PSE.VN
1 hour ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of PSE.VN.

PSE.VN Daily Candlestick Chart
ICG.VN
1 hour ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ICG.VN.

ICG.VN Daily Candlestick Chart
PNJ.VN
1 hour ago

I found you a MACD Bullish Reversal Divergence on the daily chart of PNJ.VN.

PNJ.VN Daily Candlestick Chart
ICT.AU
2 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of ICT.AU.

ICT.AU Daily Candlestick Chart
CEI.PSE
2 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of CEI.PSE.

CEI.PSE Daily Candlestick Chart
VUL.PSE
3 hours ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of VUL.PSE.

VUL.PSE Daily Candlestick Chart
PHA.PSE
3 hours ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of PHA.PSE.

PHA.PSE Daily Candlestick Chart
CIP.AU
3 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of CIP.AU.

CIP.AU Daily Candlestick Chart